These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 19129259)

  • 1. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier.
    Satchell SC; Braet F
    Am J Physiol Renal Physiol; 2009 May; 296(5):F947-56. PubMed ID: 19129259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Glomerular Filtration in Diabetes Is Attributable to Loss of Density and Increased Resistance of Glomerular Endothelial Cell Fenestrations.
    Finch NC; Fawaz SS; Neal CR; Butler MJ; Lee VK; Salmon AJ; Lay AC; Stevens M; Dayalan L; Band H; Mellor HH; Harper SJ; Shima DT; Welsh GI; Foster RR; Satchell SC
    J Am Soc Nephrol; 2022 Jun; 33(6):1120-1136. PubMed ID: 35292439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF.
    Satchell SC; Tasman CH; Singh A; Ni L; Geelen J; von Ruhland CJ; O'Hare MJ; Saleem MA; van den Heuvel LP; Mathieson PW
    Kidney Int; 2006 May; 69(9):1633-40. PubMed ID: 16557232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties.
    Satchell SC; Anderson KL; Mathieson PW
    J Am Soc Nephrol; 2004 Mar; 15(3):566-74. PubMed ID: 14978158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unique structural and functional characteristics of glomerular endothelial cell fenestrations and their potential as a therapeutic target in kidney disease.
    Finch NC; Neal CR; Welsh GI; Foster RR; Satchell SC
    Am J Physiol Renal Physiol; 2023 Oct; 325(4):F465-F478. PubMed ID: 37471420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx.
    Singh A; Ramnath RD; Foster RR; Wylie EC; Fridén V; Dasgupta I; Haraldsson B; Welsh GI; Mathieson PW; Satchell SC
    PLoS One; 2013; 8(2):e55852. PubMed ID: 23457483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium.
    Foster RR; Slater SC; Seckley J; Kerjaschki D; Bates DO; Mathieson PW; Satchell SC
    Am J Pathol; 2008 Oct; 173(4):938-48. PubMed ID: 18772335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular endothelial cells form diaphragms during development and pathologic conditions.
    Ichimura K; Stan RV; Kurihara H; Sakai T
    J Am Soc Nephrol; 2008 Aug; 19(8):1463-71. PubMed ID: 18480313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of Dab2 is involved in inhibited VEGF-VEGFR-2 signaling induced by downregulation of syndecan-1 in glomerular endothelial cell.
    Jing Z; Jia-Jun W; Wei-Jie Y
    Cell Biol Int; 2020 Mar; 44(3):894-904. PubMed ID: 31868265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High glucose causes dysfunction of the human glomerular endothelial glycocalyx.
    Singh A; Fridén V; Dasgupta I; Foster RR; Welsh GI; Tooke JE; Haraldsson B; Mathieson PW; Satchell SC
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F40-8. PubMed ID: 20980411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor increases GEnC permeability by affecting the distributions of occludin, ZO-1 and tight juction assembly.
    Zhang L; Liu H; Peng YM; Dai YY; Liu FY
    Eur Rev Med Pharmacol Sci; 2015; 19(14):2621-7. PubMed ID: 26221892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular endothelial cell maturation depends on ADAM10, a key regulator of Notch signaling.
    Farber G; Hurtado R; Loh S; Monette S; Mtui J; Kopan R; Quaggin S; Meyer-Schwesinger C; Herzlinger D; Scott RP; Blobel CP
    Angiogenesis; 2018 May; 21(2):335-347. PubMed ID: 29397483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular Endothelial Cells: Assessment of Barrier Properties In Vitro.
    Ramnath RD; Satchell SC
    Methods Mol Biol; 2020; 2067():145-151. PubMed ID: 31701451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute laminar shear stress reversibly increases human glomerular endothelial cell permeability via activation of endothelial nitric oxide synthase.
    Bevan HS; Slater SC; Clarke H; Cahill PA; Mathieson PW; Welsh GI; Satchell SC
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F733-42. PubMed ID: 21775480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway.
    Hägele H; Allam R; Pawar RD; Reichel CA; Krombach F; Anders HJ
    Am J Pathol; 2009 Nov; 175(5):1896-904. PubMed ID: 19834059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of Syndecan-1 induce glomerular endothelial cell dysfunction through modulating internalization of VEGFR-2.
    Jing Z; Wei-Jie Y; Yi-Feng ZG; Jing H
    Cell Signal; 2016 Aug; 28(8):826-37. PubMed ID: 27075925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro model of the glomerular capillary wall using electrospun collagen nanofibres in a bioartificial composite basement membrane.
    Slater SC; Beachley V; Hayes T; Zhang D; Welsh GI; Saleem MA; Mathieson PW; Wen X; Su B; Satchell SC
    PLoS One; 2011; 6(6):e20802. PubMed ID: 21731625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the glomerular endothelium in albumin handling.
    Satchell S
    Nat Rev Nephrol; 2013 Dec; 9(12):717-25. PubMed ID: 24080802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic Nephropathy.
    Onions KL; Gamez M; Buckner NR; Baker SL; Betteridge KB; Desideri S; Dallyn BP; Ramnath RD; Neal CR; Farmer LK; Mathieson PW; Gnudi L; Alitalo K; Bates DO; Salmon AHJ; Welsh GI; Satchell SC; Foster RR
    Diabetes; 2019 Jan; 68(1):172-187. PubMed ID: 30389746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empagliflozin protects glomerular endothelial cell architecture in experimental diabetes through the VEGF-A/caveolin-1/PV-1 signaling pathway.
    Locatelli M; Zoja C; Conti S; Cerullo D; Corna D; Rottoli D; Zanchi C; Tomasoni S; Remuzzi G; Benigni A
    J Pathol; 2022 Apr; 256(4):468-479. PubMed ID: 35000230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.